Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02250183 · ClinicalTrials.gov registry record · NA

Medihoney and Santyl for Burn Injuries

A NA study, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

Terminated
Registry status
NA
Development phase
21
Enrollment target

NCT02250183 is a NA study that was terminated before completion, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02250183, a NA study, was terminated before completion, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

TERMINATED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

This study is designed to assess the efficacy of MEDIHONEY® Gel with Active leptospermum honey dressing relative to SANTYL® ointment dressing on time to heal, bacterial growth in the wound, patient satisfaction, and treatment costs in patients with partial thickness burns. The study has four hypotheses: 1. It is hypothesized that MEDIHONEY® Gel with Active leptospermum honey will result in significantly faster wound healing (i.e., fewer days) when compared to SANTYL®. 2. It is hypothesized that MEDIHONEY® Gel with Active leptospermum honey sites will yield significantly fewer positive cultures for Pseudomonas aeruginosa and other bacteria when compared to SANTYL® sites. 3. It is hypothesized that patients will provide significantly higher patient care satisfaction ratings regarding their MEDIHONEY® Gel with Active leptospermum honey sites when compared to ratings with regard to their SANTYL® sites. 4. It is hypothesized that treatment costs, across participants, will be significantly lower for MEDIHONEY® Gel with Active leptospermum honey than for SANTYL®.

Interventions

  • DEVICE MEDIHONEY® GEL WITH ACTIVE LEPTOSPERMUM HONEY
  • DEVICE Santyl

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2014-03-15
Est. Completion 2016-08-18
Phase NA

What the Registry Record Tells You About NCT02250183

The ClinicalTrials.gov registry entry for NCT02250183 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which MEDIHONEY® GEL WITH ACTIVE LEPTOSPERMUM HONEY is the first listed.

NCT02250183 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02250183 about?

NCT02250183 is a clinical study titled "Medihoney and Santyl for Burn Injuries". This study is designed to assess the efficacy of MEDIHONEY® Gel with Active leptospermum honey dressing relative to SANTYL® ointment dressing on time to heal, bacterial growth in the wound, patient satisfaction, and treatment costs in patients with partial thickness burns. The study has four hypothe...

What is the current status of trial NCT02250183?

This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2014-03-15. Estimated completion is 2016-08-18.

What interventions are being tested in trial NCT02250183?

The interventions under investigation include: MEDIHONEY® GEL WITH ACTIVE LEPTOSPERMUM HONEY (DEVICE), Santyl (DEVICE).

Who is sponsoring clinical trial NCT02250183?

This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.